Skip to main content

TEX13B Antibody [FITC]

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-06129F

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP3-06129F

Key Product Details

Species Reactivity

Human

Applications

Immunohistochemistry-Paraffin

Label

FITC (Excitation = 495 nm, Emission = 519 nm)

Antibody Source

Polyclonal Rabbit IgG

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

Produced in rabbits immunized with E. coli-derived Human TEX13B fragment.

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Applications for TEX13B Antibody [FITC]

Application
Recommended Usage

Immunohistochemistry-Paraffin

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Antigen and protein A Affinity-purified

Formulation

PBS

Preservative

0.05% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: TEX13B

The TEX13B gene is similar to a mouse gene that is expressed in the testis. [provided by RefSeq]

Alternate Names

testis expressed 13B, testis expressed sequence 13B, testis-expressed sequence 13B protein, TGC3B, TSGA5

Gene Symbol

TEX13B

Additional TEX13B Products

Product Documents for TEX13B Antibody [FITC]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for TEX13B Antibody [FITC]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...